GLP Watchdog

GoodRx vs Wisp

Neither GoodRx nor Wisp has an FDA warning letter on record. No price lines up like for like: GoodRx and Wisp publish prices for different products.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

GoodRx / Wisp

GoodRx logo

GoodRx

7.8/10

Wisp logo

Wisp

7.1/10

FDA warning letters
None on record
None on record
Pharmacy
Brand-name only; no compounding
None named in our record
Lowest standing price
$149/moFoundayo (orforglipron) pill
$225/moCompounded oral semaglutide
States
48 states
39 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked September 2026
Visit GoodRx
Visit Wisp

Neither GoodRx nor Wisp pays us. Links to them earn nothing. Scores: GoodRx 7.8, Wisp 7.1. How we are paid

What the record shows

  1. 01

    Neither GoodRx nor Wisp has an FDA warning letter on record.

  2. 02

    Wisp names no compounding pharmacy in our record. GoodRx sells brand-name medication only.

  3. 03

    No price lines up like for like: GoodRx and Wisp publish prices for different products.

  4. 04

    Only GoodRx lists a price for brand-name tirzepatide pen and Foundayo (orforglipron) pill. Only Wisp lists a price for compounded oral semaglutide.

  5. 05

    GoodRx covers nine states Wisp does not.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

GoodRx

Wisp

Brand-name tirzepatide pen

$299/mo

$3,588 a year

Not sold or not priced
Compounded oral semaglutide
Not sold or not priced

$225/mo

$2,700 a year

Foundayo (orforglipron) pill

$149/mo

$1,788 a year

Not sold or not priced
Price includes
Not stated
Medication, shipping
Cancel any time
Yes, stated
Yes, stated
Minimum term
None
Not stated
Refunds
Services and medication are generally non-refundable
All sales are final

Read off each seller’s own pages. GoodRx: October 30, 2026. Wisp: September 28, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for GoodRx

7.8/10
  • Sells brand-name tirzepatide pen and Foundayo (orforglipron) pill, which Wisp does not price
  • Lists 48 states against 39
Visit GoodRx

The case for Wisp

7.1/10
  • Sells compounded oral semaglutide, which GoodRx does not price
  • Names no compounding pharmacy
Visit Wisp

Scores

GoodRx 7.8 · Wisp 7.1 out of 10. Six weighted parts.

Value25%

8.7A
vs
B
4.1

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

5.0A
vs
B
8.0

Trust & Safety15%

6.0A
vs
B
7.5

Accessibility10%

9.7A
vs
B
8.2

Support10%

5.0A
vs
B
4.5

The score is the same formula for every seller. Payment does not enter it. Method

GoodRx vs Wisp: questions

Neither GoodRx nor Wisp has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Wisp names no compounding pharmacy in our record. GoodRx sells brand-name medication only.
No price lines up like for like: GoodRx and Wisp publish prices for different products. We only set two prices against each other when they are for the same product and both are standing month-to-month or 4-week rates.
GoodRx states you can cancel at any time; refunds: services and medication are generally non-refundable. Wisp states you can cancel at any time; refunds: all sales are final.
Neither GoodRx nor Wisp pays us. Links to them earn nothing. Scores: GoodRx 7.8, Wisp 7.1.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks